Select Page

2024

Is It Cold in Here? Focal Cryoablation for Prostate Cancer

Is It Cold in Here? Focal Cryoablation for Prostate Cancer

Posted by | Aug 2024

Louis Krane, MD, explores the efficacy and clinical outcomes of focal cryoablation as a treatment for prostate cancer, emphasizing the procedure’s precision and its role in contemporary prostate cancer management.

Dr. Krane reviews the focal cryoablation technique, which allows for targeted treatment of cancerous regions within the prostate while minimizing collateral damage to essential structures such as the urethra, bladder neck, and neurovascular bundles. He also reviews patient selection criteria. Dr. Krane presents data indicating favorable rates of biochemical recurrence-free survival, with cryoablation offering a comparable efficacy to traditional treatments.

Further, Dr. Krane addresses the technical advancements that have enhanced the precision and safety of cryoablation, including the development of better imaging techniques and temperature monitoring systems.

Read More
Pew Pew! Laser Applications for Prostate Ablation

Pew Pew! Laser Applications for Prostate Ablation

Posted by | Aug 2024

Steven Canfield, MD, examines the innovative use of laser technology for prostate ablation in the management of prostate cancer. Dr. Canfield emphasizes the procedure’s precision, safety, and efficacy, positioning it as a significant advancement in prostate cancer treatment.

Dr. Canfield reviews the mechanisms of laser ablation under real-time imaging guidance, often using ultrasound or MRI. He asserts that this approach allows for the precise targeting of cancerous lesions, reducing the risk of damage to critical anatomical structures such as the neurovascular bundles and urinary sphincter.

Dr. Canfield highlights patient selection criteria and presents clinical outcome data that demonstrates promising results of laser ablation. He addresses the technological advancements that have enhanced the effectiveness and safety of the procedure, including improved imaging techniques and laser delivery systems.

Read More
Versatile Irreversible Electroporation

Versatile Irreversible Electroporation

Posted by | Aug 2024

Phillip Stricker, MBBS, explores irreversible electroporation (IRE), a novel non-thermal ablative technique, in the treatment of prostate cancer, highlighting its versatility and efficacy. To begin his presentation, Dr. Stricker reviews the IRE procedure, which involves inserting electrodes into the prostate under image guidance (typically ultrasound or MRI), and patient selection criteria.

Dr. Stricker continues by discussing the promising clinical outcomes of IRE, and advancements in IRE technology.

Read More
The Risks and Benefits of Rectal Spacers

The Risks and Benefits of Rectal Spacers

Posted by | Aug 2024

Srinivas Vourganti, MD, analyzes the risks and benefits associated with the use of rectal spacers in oncologic prostate care. His discourse emphasizes the role of rectal spacers in mitigating radiation-induced toxicity during prostate cancer radiotherapy, highlighting their potential to enhance treatment efficacy and patient quality of life.

Dr. Vourganti discusses the primary benefit of rectal spacers and examines the procedural aspects and safety profile of rectal spacer insertion. Dr. Vourganti also addresses the potential risks and limitations of rectal spacers, highlighting rare but possible complications, including infection, spacer migration, and discomfort during the insertion process.

Dr. Vourganti emphasizes the importance of patient selection and individualized treatment planning when considering the use of rectal spacers, and advocates for a thorough evaluation of each patient’s specific clinical scenario to determine the potential benefits and risks.

Read More
Imaging and Biomarkers in Patient Selection for Focal Ablation

Imaging and Biomarkers in Patient Selection for Focal Ablation

Posted by | Aug 2024

Ezequiel Becher, MD, discusses the critical role of imaging and biomarkers in selecting patients for focal ablation in prostate cancer treatment.

He highlights the advancements in imaging technologies that have revolutionized prostate cancer diagnostics, particularly multiparametric MRI (mpMRI). In addition to imaging, Dr. Becher underscores the significance of biomarkers in patient selection. While prostate-specific antigen (PSA) levels are traditionally used, they are complemented by more specific biomarkers such as PCA3, TMPRSS2-ERG, and genomic tests that provide a deeper understanding of tumor biology and aggressiveness.

Dr. Becher also addresses the challenges and limitations of current imaging and biomarker techniques. He advocates for continuous refinement of these technologies and the development of standardized protocols to enhance diagnostic accuracy. Looking forward, he points to the potential of artificial intelligence and machine learning in improving diagnostic precision and patient selection processes.

Read More

Join the GRU Community

- Why Join? -